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Introduction
Squamous cell cancer of the head and neck is
common worldwide with a prevalence of 4% and 5% in
USA and UK respectively.1 In Pakistan it is the second most
common malignancy in both males and females, after breast
cancer in females and lung cancer in males.2
Smoking tobacco, drinking alcohol and having a
poor diet are important known risk factors in the West. In
the subcontinent, chewing betel or areca nuts, smoking
bidis, and taking snuff are important risk factors.1
The prognosis of head and neck cancer depends
largely on the stage of presentation, with the single most
important factor being the presence of neck node
metastases, which reduces long-term survival by 50%.1
Recently, however, concerns have been expressed about the
weakness of the TNM classification for several head and
neck cancer sites, as the cure rates reported in the literature
vary and prognosis is not sufficiently related to the TNM
values.3 Several later studies reported the primary tumour
volume to be the important factor in determining the
outcome of treatment in head and neck carcinomas.4-8
In this study we explored the prognostic significance
of tumour volume on the outcome of patients with
squamous cell carcinoma of the head and neck.
Methodology
The retrospective review was conducted from May
2007 to November 2008. All patients had to have biopsy-
proven, previously untreated, squamous cell carcinoma of
the oral cavity, hypopharynx or larynx; measurable or
assessable disease; no synchronous primary tumours; and
age > 18 years. Initially, 130 patients with head and neck
squamous cell carcinoma (HNSCC) treated at Aga Khan
University Hospital (AKUH), Karachi, Pakistan, were
selected. Of them 40 (30.76%) patients were excluded
because of the unavailability of a pre-operative three
dimensional CT scan for our review (not done at AKUH).
Another 18 (13.85%) patients were surgically treated for
recurrent disease (locally or regionally) who were also
excluded. The remaining 72 (55.38%) patients were
selected and their pre-op CT scans (within one month) were
reviewed by a radiologist. The history of the patients was
reviewed from their medical records.
The research tool was a questionnaire designed by
the reviewers to encompass all details of the patients. It
1129 J Pak Med Assoc
Association between tumour volume and recurrence of squamous
cell carcinoma of the head and neck
Faraz Nasim Kazmi,1Amina Adil,2 Shehzad Ghaffar,3 Farhan Ahmed4
Aga Khan University Hospital, Karachi, Pakistan,1,2 Section of Otolaryngology Head & Neck Surgery, Department of Surgery, King Abdul Aziz Medical
City National Guards Health Affairs, Riyadh, Kingdom of Saudi Arabia,3 Department of Radiology, King Hamad University Hospital, Bahrain.4
Corresponding Author: Shehzad Ghaffar. Email: shehzadgm@gmail.com
Abstract
Objective: To evaluate the prognostic significance of computerized tomography derived tumour volume for
squamous cell cancers of the head and neck, treated primarily by surgery. 
Methods: The retrospective review study comprised 72 patients with head and neck malignancies who were
treated primarily by surgery at Aga Khan University Hospital, Karachi, with/without adjuvant. It was done from
May 2007 to November 2008. Each patient was followed up for a minimum of one year to check for recurrence.
For statistical analysis SPSS 17 was used. Frequencies, cross-tabulations with chi square tests to find
associations, binary logistic regression analysis, Cox regression analysis and receiver operating characteristic
curve tests were run on the data. 
Results: Overall, the median tumour volume for patients with recurrent disease was 52cm³ compared to 22cm³
for those who did not have a recurrence. It was found that large tumour volume was associated with a
significantly higher chance of recurrence (p = 0.009). Laryngeal cancers with volumes greater than 46cm³ and
oral cancers with volumes greater than 23.1cm³ were associated with poor prognosis.
Conclusions: The primary tumour volume can represent an important prognostic factor for treatment outcome.
Patients with larger primary tumour volumes should be treated more aggressively.
Keywords: Tumour volume, Head and neck Neoplasms, Cancer,  Recurrence. (JPMA 62: 1129; 2012)
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consisted of three parts. The first part included demographic
information, including age, gender and presence of any
identifiable risk factors for developing head and neck
malignancies; such as smoking, betel nut chewing or family
history of any malignancies. The second part consisted of
details of the primary tumour which were obtained both by
review of the pre-surgery CT scan as well as the patients'
files. The tumour volume consisted of CT-derived volume
of the primary tumour and volume of positive lymph nodes
(>1cm along the longest dimension). The surgical
procedure, histopathology details of the excised tumour as
well as the use of neo-adjuvant or adjunct radiotherapy and
chemotherapy were also noted. The third part dealt with
prognosis, and details of recurrence, if any, were noted.
Date of recurrence was also noted to calculate disease-free
interval. Files were reviewed until November 2009 to have
at least 1-year follow-up for all the patients.
The whole procedure of the CT review, tumour
delineation, digitisation of images and tumour volumetric
calculations were coordinated by an experienced head-and-
neck radiologist who was unaware of the patients' outcome.
For calculation of the tumour volume, dimensions were
taken in the cranoicaudal, anteroposterior and transverse
dimensions and then multiplied to get the tumour volume.
Lymph nodes of at least 1cm in the longest dimension were
considered involved and their volume was also calculated
and added to the primary tumour volume to obtain the total
tumour volume. Measurements were done twice. If these
values varied by l0% or less, an average of the two readings
was used as the measured volume. If the variation exceeded
l0%, another two measurements were made and an average
of the four readings was used as the measured volume.
For statistical analysis, SPSS version 17 was used.
Besides, chi square test, binary logistic regression analysis,
Cox regression analysis and receiver operating
characteristic (ROC) curve tests were run on the data. 
Results
Of the 72 patients in the study, 53 (73.61%) were
male and 19 (26.38%) were female, with an average age of
52±13 years. The study group was divided according to the
site of tumour (American Joint Committee on Cancers
[AJCC] 2002 classification)9 with 49 (68.1%) being oral
cancers, 16 (22.2%) laryngeal cancers and 6 (8.3%) being
hypopharyngeal cancers and 1 (1.38%) case was that of
periauricular tumour.
Of all the patients, 47 (65.3%) were betel nut
chewers, 26 (36.1%) were smokers and 8 (11.1%) had a
positive family history of malignancies. Besides, 40 of the
49 (81.63%) oral cavity cancer patients were betel nut
chewers, showing a significant association between
developing oral cavity cancer and betel nut chewing (p =
0.001) (Figure-1).
Smoking status, positive family history or betel nut
chewing did not show significant correlation with the
increasing tumour volume.
The bulk of the tumours in our sample - 55 (76.4%)
- were moderately differentiated squamous cell carcinomas;
10 (13.9%) had well-differentiated squamous carcinomas;
and 2 (2.8%) were poorly-differentiated squamous cell
carcinomas. Another 3 (4.2%) cases were described as
moderate to poorly differentiated squamous cell carcinomas
and 2 (2.8%) were described as moderate to well
differentiated squamous cell carcinomas.
Eight (11.1%) had infiltrating and keratinising
cancers; 21 (29.2%) had only keratinizing; and 14 (19.2%)
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Figure-1: Category of tumours.
Figure-2: Receiver Operating Characteristic (ROC) curve of oral cancer recurrence.
had only infiltrating cancers. The rest of the 29 (40.27%)
cases were neither keratinising nor infiltrating. The tumour
differentiation statistically did not predict recurrence for
patients in the study.
Overall, 27 (37.5%) patients had recurrence of
malignancy during the study period. Of the 49 patients with
oral cancers, 19 (38%) had recurrent disease; 7 (43.8%) out
of 16 laryngeal cancer patients showed recurrence; and 1
(16.7%) out of 6 hypopharyngeal malignancies recurred
(Table-1).
Of the patients who had recurrence, the median
recurrence time was around 4 months (mean 7±8 months).
The recurrence times for tumour subtypes were similar, with
the median time for oral cancers being 4 months and of
laryngeal cancers being 5 months.
It was noted that tumours with the shortest surgical
margin >4mm had a lesser chance of having recurrence.
Only 23% of cases with margin >4mm recurred as opposed
to 42% in those tumours whose margins were < 4mm.
However, the trend of decreasing margins with increased
recurrence was not statistically significant in our study.
Overall, the median tumour volume of patients who
had recurrence of disease (52cm³) was more than twice that
of those who did not have recurrence (22.0cm³) (Table-2).
This observation was consistent for all tumour subtypes. 
Following surgery, 17 (23.6%) patients received
both radiotherapy and chemotherapy; 26 (36.1%) received
radiotherapy alone; 3 (4.2%) received chemotherapy alone
and 26 (36.1%) received neither radiotherapy nor
chemotherapy. The use of chemotherapy and radiotherapy
either alone or in combination was not found to be
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Figure-3: Receiver Operating Characteristic (ROC) curve of laryngeal cancer
recurrence.
Table-1: Mean recurrence times.
Tumour category Number of cases Mean recurrence time (months) (SD*) Median recurrence time (months) Interquartile range
Oral 19 7.5 ± 8.8 4 5
Laryngeal 7 7.8 ± 5.2 5 10
Hypopharyngeal 1 2.0 ± 0 2 0
Total 27 7.3 ± 8.0 4 5
Only cases with positive recurrence are noted here. *SD: standard deviation.
Table-2: Radiological total tumour volume.
Category of tumour Median volume- Positive recurrence Interquartile Range Median volume- negative recurrence Interquartile range
Oral 37.0cm³ 63.8 20.2cm³ 33.2
Hypopharyngeal 115.0cm³ NA* 38.9cm³ 23.9
Laryngeal 80.9cm³ 91.1 29.0cm³ 64.3
Total 52.1cm³ 102.6 22.0cm³ 36.5
*There was only one case of recuurence of hypopharyngeal cancer.
Table-3: Median Tumour Volume of patients who received adjuvant therapy.
Recurrence
Adjuvant Therapy Yes Interquartile range No Interquartile range
Both Radiotherapy and chemotherapy 80.6 80 18.6 22.9
Only chemotherapy 18.9 NA* 10.4 NA*
Only radiotherapy 67.3 95.4 29.0 40.0
No adjuvant therapy 52.1 93.2 20.2 55.8
*Only 3 patients received chemotherapy alone.
statistically significant in our study.
Among patients who received adjuvant therapy,
those with recurrence were found to have higher tumour
volumes (Table-3). Patients who received a combination
adjuvant therapy and had a positive recurrence had a median
tumour volume of 80cm³. In contrast, patients with
recurrence who had received no adjuvant therapy had a
median tumour volume of 52.1cm³.
Binary logistic regression revealed a positive
correlation between increasing tumour volume and odds of
developing recurrence (p = 0.009) (95% confidence interval
1.004-1.030). The results showed that with a 1-point
increase in tumour volume (i.e. 1cm³), the odds of
recurrence went up by 1.7% (p = 0.009).
It was also noted that above a critical value of
23.1cm³, oral cancers had a greater chance of showing
recurrence (63% sensitivity and 63.2% specificity). Besides,
26.9% tumours (7 out of 26) below the cutoff recurred as
opposed to 52.1% (12 out of 23) above the cutoff (Figure-2)
Similarly, for laryngeal cancer, the cutoff was
46.0cm³, above which there was a greater chance that the
tumour recurred (71.4% sensitivity and 66.7% specificity).
Besides, 25% (2 out of 8) had positive recurrence below this
cutoff and 62.5% (5 out of 8) had positive recurrence above
it (Figure-3).
Discussion
The results demonstrated that significant
association existed between tumour volume of head and
neck cancers (oral and laryngeal) and prognosis of the
same after surgery. 
Previously, tumour volume has been shown to be a
predictor for prognosis in glottic, supraglottic,
nasopharyngeal and hypopharyngeal cancers treated with
radiotherapy alone10-15 or concurrent chemo-radiation.4,6
Data from other head and neck cancers has revealed that
volume of oropharyngeal cancer did not have an important
impact on local control after radiotherapy8,16 or surgery5
although some studies do report association between the
two.6 To our knowledge, no study has investigated the
prognostic impact of tumour volumetry of oral cavity
cancers. Regarding the relationship of prognosis with
tumour volume in patients treated primarily by surgery,
limited data is available which finds a positive association
between tumour volume and prognosis in supraglottic
squamous cell carcinoma.17
Different studies show a wide range of volumetric
cutoffs above which tumour recurrence becomes more
likely. This may be possible due to the different modalities
used in treating the patients and/or hospital/surgeon
techniques and possibly due to the different ethnic groups
being studied. 
There is a large variation in the cutoff values for
determining prognosis for laryngeal tumours treated with
radiotherapy or chemo radiation ranging from 3.5cm³18-20
up to 112cm³.7 Several authors used the mean gross tumour
volumes (GTV) as the cutoff point. For tumours treated
primarily by surgery, a cutoff of 16cm³ has been reported to
predict local control and survival in patients with
supraglottic cancers.17 Such cutoffs are not available for
oral cavity cancers since tumour volume has not been
compared to prognosis in much detail. We found that
tumour volume was associated with local recurrence and
control both for laryngeal and oral cavity cancers. The
cutoff that we report is not the mean GTV. According to our
data, tumour recurrence can be predicted with a cutoff of
about 23cm³ for oral cavity cancers, and 46cm³ for
laryngeal cancers.
Further analysis of our data revealed that one-point
increase in tumour volume was associated with
approximately 1.7% increase in risk of recurrence,
indicating that even in groups in the same cutoff range, the
bulkier tumour was at a higher risk of recurrence. 
According to our data, tumour volume seems to be
significantly correlated with prognosis for both laryngeal
and oral cavity cancers with the bulkier tumours having
greater chance of failure to control the disease. 
Thus we recommend that in addition to AJCC TNM
staging, clinicians also use tumour volume to ascertain the
aggressiveness of treatment. This is because any one T stage
can have a wide variety of volumes within it. As such, we
recommend that subsequent high-risk and low-risk groups
be made to decide what course of action to take in a patient's
treatment. We also suggest larger studies with different
ethnic groups represented so a clearer picture about the
strength of the association between volume and prognosis
can be ascertained. 
Conclusion
In advanced T-staged (T3 and T4) head and neck
cancers, a substantial variation of primary tumour volume is
present within the same T stage and primary tumour volume
can represent an important prognostic factor for treatment
outcome. Volumetric measurements can help to refine the
TNM staging system as they afford an even sharper view
considering the wide variation of size seen within the same
stage. Based on our results we recommend that patients with
larger primary tumour volumes should be treated more
aggressively. 
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